Company intelligence / Profile preview

NovaSom

Glen Burnie, Maryland, United States

Ownership: Private
Development stage: Other

Overview

NovaSom pioneered FDA-cleared home sleep testing devices for obstructive sleep apnea and demonstrated clinical equivalence to lab-based polysomnography in peer-reviewed publications. Its services enabled cost-effective, in-home OSA diagnostics covered by major US insurers and were clinically adopted until acquisition. Clinical studies showed equivalent sensitivity and specificity to lab testing over multiple nights.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

UnitedHealthcareHealthAmerica

Beyond the preview

Go deeper on NovaSom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NovaSom.

Explore the full profile